22 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
-Terrorism Laws.
Section 3.23. Broker’s Fees.
Section 3.24. Data Privacy and Information Security.
Article IV. REPRESENTATIONS AND WARRANTIES … with this Agreement.
Section 3.24.Data Privacy and Information Security.
(a)The Company and its Subsidiaries maintain industry appropriate data security policies
8-K
EX-1.1
r7ym8z2ko6w 6q7ye1u
16 Jul 20
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
5:15pm
10-K
9ko 7ssrzfbadga447p
26 Feb 20
Annual report
4:53pm
424B4
a1ene 0cvr
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
jp5dl1z0
9 Jan 20
Draft registration statement
12:00am
424B4
knwuk4yqbhj4
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
EX-10.2
1h4wt4c
30 May 19
IPO registration
5:20pm
S-1
kzn5fxtf6ak0k2u3q5p
30 May 19
IPO registration
5:20pm
DRS/A
EX-10.2
s2j7w6c0fje4gvx6i
8 May 19
Draft registration statement (amended)
12:00am